Lung Foundation Australia has today launched its new corporate plan, Lung Health for All (2026–2030), setting out an ambitious national strategy to improve lung health across the life course, from a child’s first breath through to older age.
CEO Mark Brooke said the strategy represents a significant change in how lung health is understood and addressed in Australia, with a stronger focus on prevention, equity and national collaboration.
“This is a bold plan to elevate lung health to where it needs to be, alongside other national health priorities,” Mr Brooke said.
“If you have lungs, you have a reason to care about lung health. This strategy is about ensuring every Australian can breathe easier, live well and feel supported at every stage of life.”
A key focus of the strategy is shifting the perception of lung disease, moving away from outdated assumptions and stigma, and towards a broader understanding that lung disease and lung cancer can affect anyone.
Despite its widespread impact, three in five Australians living with lung disease or lung cancer report experiencing stigma, including within the healthcare system.
Lung Foundation Australia has played a leading role in driving national reform, including its advocacy for the National Lung Cancer Screening Program which launched on 1st July 2025 and has already screened more than 65,000 Australians.
Mr Brooke said the program demonstrates what is possible when evidence, policy and advocacy align.
“Early detection saves lives, but only if people can access screening and care without fear or stigma,” he said.
“We’ve worked closely with governments and partners to help make this program a reality, and it’s already making a meaningful difference.”
The strategy outlines clear national priorities, including lifelong lung health and prevention, protection against respiratory infections, reducing tobacco and vaping harm, improving air quality, safer workplaces, and supporting people to live well with lung disease, all underpinned by a strong commitment to equity.
It has been shaped by 18 months of national consultation, including the largest lived experience survey in Lung Foundation Australia’s history, with 56 submissions, 67 interviews and 11 national workshops informing its direction, brand and five-year research strategy.
Research and innovation remain central to delivering on the plan. Lung Foundation Australia recently recognised 20 recipients of its 2026 Grants and Awards Program, representing almost $3 million in research funding to advance earlier diagnosis, improve treatment and strengthen care for people living with lung disease. The program is made possible through the generosity of donors, philanthropic partners, corporate supporters and the broader community.
Lung Foundation Australia Board Chair and respiratory physician Professor Lucy Morgan said continued investment in research is critical to improving outcomes.
“Research is essential to driving earlier detection, better treatments and more effective care, and ensuring people with lung disease receive the support they need,” Professor Morgan said.
For more than 30 years, Lung Foundation Australia has supported Australians through trusted information, nurse-led services, peer support and advocacy, while working closely with governments to drive policy change and investment in lung health.
Mr Brooke said the new strategy signals a more ambitious future.
“Everything we do is about protecting the gift of breath, so more Australians can breathe easier, live well and feel less alone,” he said.
Further initiatives and national activities will be rolled out in the lead-up to Lung Health Awareness Month in May.
Was this page helpful?
Good job! Please give your positive feedback
How could we improve this post? Please Help us.
